Assessing the lung cancer risk reduction potential of candidate modified risk tobacco products

Smoking is the major cause of lung cancer. While the risk of lung cancer increases with the number of cigarettes smoked and the duration of smoking, it also decreases upon smoking cessation. The development of candidate modified risk tobacco products (cMRTP) is aimed at providing smokers who will no...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoeng, Julia, Maeder, Serge, Vanscheeuwijck, Patrick, Peitsch, Manuel C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Im - Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722152/
https://www.ncbi.nlm.nih.gov/pubmed/30767158
http://dx.doi.org/10.1007/s11739-019-02045-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722152/
https://www.ncbi.nlm.nih.gov/pubmed/30767158
http://dx.doi.org/10.1007/s11739-019-02045-z

Ejemplares similares